NATALIE EARLY GILLESPIE ARNOLD
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ROANOKE, VA NPI 1700242542
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VA Genentech USA, Inc. All categories
General Payments — all program years on this page
$245.34
- Category: General Payments
- Program years: PY2023–2024
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $158.41 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.41 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $50.16 | 2 |
| Acerta Pharma LLC | $34.24 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.06 | 1 |
| CSL Behring | $23.08 | 1 |
| Amgen Inc. | $20.87 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104385417 | AstraZeneca Pharmaceuticals LP | $15.71 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104423379 | AstraZeneca Pharmaceuticals LP | $18.53 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117192630 | Amgen Inc. | $20.87 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118118395 | Boehringer Ingelheim Pharmaceuticals, Inc. | $30.06 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133178793 | Genentech USA, Inc. | $34.66 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133178798 | Genentech USA, Inc. | $15.50 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1134632417 | CSL Behring | $23.08 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.